# Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

> **NCT03353753** · PHASE3 · COMPLETED · sponsor: **Deciphera Pharmaceuticals, LLC** · enrollment: 129 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** DCC-2618
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03353753
- **Lead sponsor:** Deciphera Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-05-31
- **Final completion:** 2022-05-11
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03353753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03353753, "Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03353753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*